Starling Oncology, Inc. Stock Repurchase Program, Number of Shares Authorized to be Repurchased
Starling Oncology, Inc. (DFPH) had Stock Repurchase Program, Number of Shares Authorized to be Repurchased of 2.00 million shares as of 2023-08-28, per its 10-Q filed 2024-05-14.
Discontinued › Notes › Equity
us-gaap:StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased · last filed 2024-05-14
- 2023-08-28: Stock Repurchase Program, Number of Shares Authorized to be Repurchased 2.00M shares.
- 2023-06-14: Stock Repurchase Program, Number of Shares Authorized to be Repurchased 5.00M shares.
- 2022-05-10: Stock Repurchase Program, Number of Shares Authorized to be Repurchased 20.00M shares.
| Period end | Stock Repurchase Program, Number of Shares Authorized to be Repurchased |
|---|---|
| 2023-08-28 | 2.00M shares 10-Q · filed 2024-05-14 |
| 2023-06-14 | 5.00M shares 10-Q · filed 2024-05-14 |
| 2022-05-10 | 20.00M shares 10-K · filed 2024-03-28 |